Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional human CFTR produced by a stable minichromosome.

Cristina Auriche1, Daniela Carpani, Massimo Conese

  • 1Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartmento di Biologia Cellulare e dello Sviluppo, University of Rome La Sapienza, Italy.

EMBO Reports
|August 22, 2002
PubMed
Summary

Researchers created a stable, functional artificial chromosome carrying the cystic fibrosis transmembrane conductance regulator (CFTR) gene. This breakthrough offers a promising vector for gene therapy, overcoming previous design and stability challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term therapy with elexacaftor/tezacaftor/ivacaftor improves cystic fibrosis lung disease and monocyte function.

Respiratory medicine·2026
Same author

Mucoactive Agents in Muco-Obstructive Lung Diseases: A Critical Reappraisal of Pharmacological Effects and Clinical Outcomes.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Editorial: ESKAPEing host endogenous and exogenous defenses: new insights into the ability of multidrug- resistant bacteria to overcome host defenses and antimicrobial compounds activity.

Frontiers in cellular and infection microbiology·2026
Same author

Iloprost-loaded inhalable Nano into Micro (NiM) formulations for treating hyper-inflammation in a pre-clinical model of cystic fibrosis airway epithelial cells.

Drug delivery and translational research·2026
Same author

Retrospective Analysis of Incidence and Etiology of Severe Infections in Children Receiving Therapy for High-Risk Neuroblastoma: A Large Single-Center Experience.

Pediatric blood & cancer·2026
Same author

A Computational Approach to Evaluating Empirical Antibiotic Coverage for Gram-Negative Bloodstream Infections in Pediatric Febrile Neutropenia.

Antibiotics (Basel, Switzerland)·2026

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Genetics

Background:

  • Artificial chromosomes are ideal vectors for gene therapy but face challenges in stability and design.
  • Producing stable, well-designed artificial chromosomes is crucial for effective gene delivery.

Purpose of the Study:

  • To clone the human cystic fibrosis transmembrane conductance regulator (CFTR) locus into a structurally defined minichromosome.
  • To assess the stability and functional activity of the engineered minichromosome for gene therapy applications.

Main Methods:

  • Utilized a 320 kb yeast artificial chromosome (YAC) 37AB12 containing the intact CFTR gene and regulatory sequences.
  • Analyzed the resulting minichromosome for CFTR gene presence, transcript, protein expression, and functional activity (chloride secretion).

Related Experiment Videos

  • Evaluated mitotic and molecular stability over prolonged growth periods without selection.

    • Main Results:

    • Successfully cloned the intact human CFTR gene into a structurally defined minichromosome.
    • Confirmed the presence of CFTR transcript and protein, along with functional chloride secretion in the engineered clones.
    • Demonstrated high mitotic and molecular stability of the minichromosome constructs during extended cultivation.

    Conclusions:

    • This study presents the first structurally characterized minichromosome containing an active therapeutic gene (CFTR).
    • The stable and functional artificial chromosome represents a significant advancement for cystic fibrosis gene therapy.
    • The developed minichromosome vector overcomes previous limitations in artificial chromosome design and stability for gene therapy.